Document is current
Any future updates will be listed below
-
Authors
,
Shima, Yuko
Nakanishi, Koichi http://orcid.org/0000-0001-8681-9129
Kaku, Yoshitsugu
Ishikura, Kenji
Hataya, Hiroshi
Matsuyama, Takeshi
Honda, Masataka
Sako, Mayumi
Nozu, Kandai
Tanaka, Ryojiro
Iijima, Kazumoto
Yoshikawa, Norishige
-
Funding
Funding for this research was provided by:
Asahi Kasei Pharma Corporation (Lecture fees, Consulting fees, Grants and lecture fees, Lecture fees, Lecture fees, Lecture fees, Lecture fees, Lecture fees)
Eizai Co. (Grants, Grants, Grants)
Takeda Pharmaceutical Company (Lecture fees, Grants and lecture fees)
Boehringer Ingelheim Japan Co. (Lecture fees, Lecture fees)
- License Information
-
More Information
Article History
Received: 2 April 2018
Revised: 20 June 2018
Accepted: 25 June 2018
First Online: 9 July 2018
Compliance with ethical standards
: The study protocol followed the Declaration of Helsinki and was in accordance with the standards of the ethics committee of Wakayama Medical University. All patients’ parents or legal guardians gave informed consent for inclusion. This study has been registered in a public trial registry, UMIN (University Hospital Medical Information Network, ID C000000363,).
: KN received lecture fees from Asahi Kasei Pharma Corp. YK received consulting fees from Asahi Kasei Pharma Corp. KI received grants from Asahi Kasei Pharma Corp. and Eizai Co. Ltd. and lecture fees from Asahi Kasei Pharma Corp. HH received lecture fees from Asahi Kasei Pharma Corp. MH received lecture fees from Asahi Kasei Pharma Corp. and Takeda Pharmaceutical Co. Ltd. MS received grants from Eizai Co. Ltd. KN received lecture fees from Asahi Kasei Pharma Corp. KI received grants from Takeda Pharmaceutical Co. Ltd. and Eizai Co. Ltd., and lecture fees and/or consulting fees from Asahi Kasei Pharma Corp., Boehringer Ingelheim Japan Co. Ltd. and Takeda Pharmaceutical Co. Ltd. NY received lecture fees from Boehringer Ingelheim and Asahi Kasei Pharma Corp. The other authors had no disclosure to declare.
